Literature DB >> 3396820

Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow.

J Zeeh1, H Lange, J Bosch, S Pohl, H Loesgen, R Eggers, M Navasa, J Chesta, J Bircher.   

Abstract

Hepatic plasma flow was assessed with sorbitol (hepatic extraction = 0.96) at steady state. After infusion of 50 mg/min for 3 h, total and renal sorbitol clearances were calculated, and the extrarenal clearance was obtained by taking the difference between the two. In normal volunteers, the mean (+/- SD) extrarenal sorbitol clearance was 10.6 +/- 2.1 ml/min.kg. In patients with various liver diseases, it was correlated more closely to the fractional clearance of indocyanine green (r = 0.83, n = 57) than the galactose elimination capacity (r = 0.66, n = 55). Hepatic vein catheterization showed that the hepatic extraction of sorbitol was always much higher than the extraction of indocyanine green; there was no evidence for extrahepatic, extrarenal sorbitol elimination. On the basis of these findings, sorbitol is kinetically superior to indocyanine green and, although the noninvasively determined extrarenal sorbitol clearance at steady state may not be equal to total hepatic plasma flow, it may at least be regarded as a measure of parenchymal liver plasma flow.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3396820     DOI: 10.1016/s0016-5085(88)80024-6

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  31 in total

Review 1.  Gastrointestinal problems related to endurance event training.

Authors:  F A Halvorsen; S Ritland
Journal:  Sports Med       Date:  1992-09       Impact factor: 11.136

2.  Quantitative tissue blood flow measurement of the liver parenchyma: comparison between xenon CT and perfusion CT.

Authors:  Kazuhiko Hashimoto; Takamichi Murakami; Keizo Dono; Masatoshi Hori; Tonsok Kim; Masayuki Kudo; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Takeda; Hiroaki Nagano; Koji Umeshita; Hironobu Nakamura; Morito Monden
Journal:  Dig Dis Sci       Date:  2007-02-23       Impact factor: 3.199

3.  Effect of pentoxifylline on liver plasma flow in normal man.

Authors:  A Suren; F E Bauer; B Rosenkranz; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 4.  Clinical pharmacokinetics in patients with liver disease.

Authors:  A J McLean; D J Morgan
Journal:  Clin Pharmacokinet       Date:  1991-07       Impact factor: 6.447

5.  Can intrahepatic shunting be measured?

Authors:  S Keiding
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

6.  Assessment of the hepatic microvascular changes in liver cirrhosis by perfusion computed tomography.

Authors:  Mai-Lin Chen; Qing-Yu Zeng; Jian-Wei Huo; Xiao-Ming Yin; Bao-Ping Li; Jian-Xin Liu
Journal:  World J Gastroenterol       Date:  2009-07-28       Impact factor: 5.742

7.  Lack of interference by sorbitol with aminopyrine breath test.

Authors:  V C Ramin; J Bircher
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

Review 8.  Assessment of liver metabolic function. Clinical implications.

Authors:  J Brockmöller; I Roots
Journal:  Clin Pharmacokinet       Date:  1994-09       Impact factor: 6.447

9.  Pilot study on the influence of liver blood flow and cardiac output on the clearance of propofol in critically ill patients.

Authors:  Mariska Y M Peeters; Leon P H J Aarts; Ferenc A Boom; Leo J Bras; Dick Tibboel; Meindert Danhof; Catherijne A J Knibbe
Journal:  Eur J Clin Pharmacol       Date:  2007-11-13       Impact factor: 2.953

Review 10.  Effect of hepatic insufficiency on pharmacokinetics and drug dosing.

Authors:  R K Verbeeck; Y Horsmans
Journal:  Pharm World Sci       Date:  1998-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.